These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 21966161)

  • 41. Economic content in medical journal advertisements for medical devices and prescription drugs.
    Ackerly DC; Glickman SW; Schulman KA
    Pharmacoeconomics; 2010; 28(5):429-38. PubMed ID: 20402543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The revised guidelines of the Medical Council of India for academic promotions: Need for a rethink.
    Aggarwal R; Gogtay N; Kumar R; Sahni P;
    J Family Med Prim Care; 2015; 4(4):483-6. PubMed ID: 26985403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Critical Evaluation of Drug Advertisements in a Medical College in Lalitpur, Nepal.
    Jha N; Sapkota Y; Shankar PR
    J Multidiscip Healthc; 2020; 13():717-725. PubMed ID: 32801734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cross-sectional study of medical advertisements in a national general medical journal: evidence, cost, and safe use of advertised versus comparative drugs.
    Boesen K; Simonsen AL; Jørgensen KJ; Gøtzsche PC
    Res Integr Peer Rev; 2021 May; 6(1):8. PubMed ID: 33971984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Barriers to Impact Factor Growth in Two Major Psychiatry Journals in India.
    D'cruz M; Andrade C
    Indian J Psychol Med; 2021 May; 43(3):241-245. PubMed ID: 34345100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systematic assessment of opioid advertisements in general medical journals.
    Kirubarajan A; Got T; Persaud N; O'Neill B
    Can Fam Physician; 2023 Mar; 69(3):192-197. PubMed ID: 36944508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Critical Review of the Drug Promotional Literature Published in Scientific Medical Journals and Available at Outpatient Departments: A Cross-Sectional Observational Study.
    Vivek K; Deolekar P; Naseem A; Langade DG; Yadav P
    Cureus; 2022 Nov; 14(11):e31283. PubMed ID: 36514598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The accuracy of psychiatric medication advertisements in medical journals.
    Spielmans GI; Thielges SA; Dent AL; Greenberg RP
    J Nerv Ment Dis; 2008 Apr; 196(4):267-73. PubMed ID: 18414120
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quality of claims and references found in Australian pharmacy journal advertisements.
    Mandoh M; Curtain CM
    Int J Pharm Pract; 2017 Oct; 25(5):365-370. PubMed ID: 27896882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Direct-to-physician and direct-to-consumer advertising: Time to have stringent regulations.
    Kannan S; Gowri S; Tyagi V; Kohli S; Jain R; Kapil P; Bhardwaj A
    Int J Risk Saf Med; 2015; 27(2):77-83. PubMed ID: 26410010
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The association between a journal's source of revenue and the drug recommendations made in the articles it publishes.
    Becker A; Dörter F; Eckhardt K; Viniol A; Baum E; Kochen MM; Lexchin J; Wegscheider K; Donner-Banzhoff N
    CMAJ; 2011 Mar; 183(5):544-8. PubMed ID: 21398223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Accuracy of references in Indian journal of otolaryngology and head & neck surgery.
    Adhikari P
    Indian J Otolaryngol Head Neck Surg; 2010 Oct; 62(4):338-41. PubMed ID: 22319688
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Where and when were the studies conducted? An examination of articles published in 2017-2018 in two leading Indian psychiatry journals.
    Andrade C; Arya T; Sivakumar K
    Asian J Psychiatr; 2020 Dec; 54():102283. PubMed ID: 32682299
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quality of claims, references and the presentation of risk results in medical journal advertising: a comparative study in Australia, Malaysia and the United States.
    Othman N; Vitry AI; Roughead EE
    BMC Public Health; 2010 May; 10():294. PubMed ID: 20509953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advertisements for medicines in leading medical journals in 18 countries: a 12-month survey of information content and standards.
    Herxheimer A; Lundborg CS; Westerholm B
    Int J Health Serv; 1993; 23(1):161-72. PubMed ID: 8425785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An investigation into the pharmaceutical advertising in Iranian medical journals.
    Yousefi N; Sharif Z; Chahian F; Mombeini T; Peiravian F
    J Pharm Policy Pract; 2022 Mar; 15(1):18. PubMed ID: 35255995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals.
    Flanagin A; Carey LA; Fontanarosa PB; Phillips SG; Pace BP; Lundberg GD; Rennie D
    JAMA; 1998 Jul; 280(3):222-4. PubMed ID: 9676661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Economic messages in prescription drug advertisements in medical journals.
    Neumann PJ; Zivin Bambauer K; Ramakrishnan V; Stewart KA; Bell CM
    Med Care; 2002 Sep; 40(9):840-5. PubMed ID: 12218774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Industry guidelines, laws and regulations ignored: quality of drug advertising in medical journals.
    Lankinen KS; Levola T; Marttinen K; Puumalainen I; Helin-Salmivaara A
    Pharmacoepidemiol Drug Saf; 2004 Nov; 13(11):789-95. PubMed ID: 15486957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal.
    Lexchin J; Holbrook A
    CMAJ; 1994 Jul; 151(1):47-54. PubMed ID: 8004560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.